Exact Sciences Corporation (NasdaqCM:EXAS) acquired Resolution Bioscience, Inc. from Agilent Technologies, Inc. (NYSE:A) for approximately $54.2 million on September 12, 2023. Of the $52.5 million of consideration to be settled through the payment of cash, $50.0 million was paid as of September 30, 2023. The remaining $2.5 million represents cash owed to the seller for reimbursement of employee-related compensation and benefit costs for pre-acquisition services. The remaining cash consideration will be held by the Company until settlement and was recorded in other current liabilities in the condensed consolidated balance sheet.

Exact Sciences Corporation (NasdaqCM:EXAS) completed the acquisition of Resolution Bioscience, Inc. from Agilent Technologies, Inc. (NYSE:A) on September 12, 2023.